Unknown Author
December 26, 2025
K2M Completes Follow-On Offering of Common Stock

1 min
AI-made summary
- K2M Group Holdings, Inc
- conducted a public offering of 6,951,738 shares of common stock at $18.75 per share, with K2M selling 2,044,990 shares and certain selling stockholders selling 4,906,748 shares, including 906,748 shares from the underwriters’ exercised option
- The shares are listed on NASDAQ under the symbol 'KTWO.' Piper Jaffray, Barclays, and Wells Fargo acted as joint book-running managers, with William Blair and Cowen as co-managers.
The Firm represented K2M Group Holdings, Inc. (“K2M”) in connection with a public offering of 6,951,738 shares of common stock by K2M and certain selling stockholders at a public offering price of $18.75 per share.
K2M sold 2,044,990 shares of common stock in the offering. The selling stockholders sold 4,906,748 shares of common stock in the offering, including 906,748 shares that were offered and sold pursuant to the full exercise of the underwriters’ option to purchase additional shares. Shares of K2M are listed on NASDAQ Global Select Market under the ticker symbol “KTWO.”
Piper Jaffray & Co., Barclays Capital Inc. and Wells Fargo Securities, LLC acted as joint book-running managers for the offering. William Blair & Company, L.L.C. and Cowen and Company, LLC acted as co-managers.
K2M is a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques.
The Simpson Thacher team included Kenneth Wallach, Jonathan Ozner, Kai Fan, Wabi Jain and Sara Campbell (Capital Markets); James Rapp and Janice Brunner (Public Company Advisory Practice); Marcy Geller and Joseph Tootle (Tax); Lindsay Thomas and Josh Bergman (Credit); David Rubinsky and Patricia Adams (Executive Compensation and Employee Benefits); and Samantha Himelman (Intellectual Property).
Article Author
Unknown Author
The Sponsor
